AlphaPheno

AlphaPheno is a biotechnology company specializing in human induced pluripotent stem cell (iPSC) technology and high-throughput phenotypic screening. Based in San Diego, the company develops physiologically relevant human disease models to improve the translatability of drug discovery efforts. Their platform integrates advanced cell engineering, automated high-content imaging, and machine learning to identify novel therapeutic candidates. AlphaPheno focuses on complex therapeutic areas including neurology, cardiology, and rare diseases, providing deep insights into disease mechanisms. The company offers both internal discovery programs and collaborative services to pharmaceutical and biotech partners. By utilizing "disease-in-a-dish" models, AlphaPheno aims to reduce the high failure rates associated with traditional animal-based drug testing.